Thora Johanna Jonasdottir

Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway.

Sundt AS is an independent investment firm headquartered in Oslo, Norway. The firm was founded by Petter C. G. Sundt in 1995. Sundt manages the holdings in Helene Sundt AS and CGS Holding AS and is responsible for the day to day operation and management of the holding companies and their associated subsidiaries, as well as own subsidiaries.

Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway.

Skagen AS (Investment Management) (Skagen-IM) is the investment management division of Skagen AS, itself a subsidiary of Storebrand ASA (OSE: STB, FRA: SKT) in Norway. The firm was founded in 1993 by Kristoffer Stensrud, Tor Dagfinn Veen and Åge Westbø. Headquartered in Stavanger, Skagen-IM manages Skagen global equity and fixed income funds for individual and institutional investors. They are a socially responsible investor.

Holmen Industri Invest 1 AS is a Norwegian investment company. The private company is based in Oslo, Norway. The CEO of the company is Karl-Erik Staubo.

LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

Biomolex AS develops and delivers imaging systems for digital autoradiography. It offers Biomolex 700, a digital imager for protein micro-array analysis, including kinase analyses, protein interaction assays, single istotope deoxyribonucleic acid array analyses, micro analyses; and tissue imaging applications, such as foreign genetic material delivery, tissue specific distributions, uptake of antibodies, and uptake of labeled bio-molecules. The company was founded in May 2001 and is headquartered in Oslo, Norway.

US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD.

Victoria Eiendom Invest AS operates as a holding company with interest in providing investment services. The company is headquartered in Oslo, Norway.

StudentUniverse.com, Inc. operates as a social booking platform for students and socially oriented travelers. The firm also offers exclusive pricing and terms on flights, hotels, and tours. The company was founded by Espen Odegard in 2000 and is headquartered in Waltham, MA.

Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden.

CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden.

Part of Chosa Oncology AB, RhoVac ApS is a Danish company that aims to prevent cancer recurrence and progression after primary tumor therapy. The company is based in Hørsholm, Denmark. The company's clinical phase II product, iCIP™ - Precision LiPlaCis® & DRP® with Breakthrough designation option, consists of LiPlaCis® and its Drug Response. Anders Månsson has been the CEO of the company since 2019.

Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France.

North Bridge Agri Ltd. owns, manages, and operates agricultural properties. It also leases farm land. The company was founded on January 20, 2010 and is headquartered in Nicosia, Cyprus.

Part of Storebrand ASA, SKAGEN AS is a Norwegian fund management company. The company is based in Stavanger, Norway. SKAGEN was founded by Kristoffer Stensrud, Geir Tjetland, Åge Kristiansen Westbø, Tor Dagfinn Veen. Timothy Warrington has been the CEO of the company since 2007.

Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway.

Occi Holding AS is a Norwegian company that leases real estate properties. The private company is based in Hamar, Norway.

Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021.